11 private hospitals and clinics in Singapore get green light to import Sinopharm vaccine

SINGAPORE (The Straits Times/ANN): The Health Sciences Authority (HSA) has approved 11 applications for private hospitals and clinics to import China's Sinopharm vaccine under the special access route (SAR).

This means the risks of using such vaccines are "fully borne by the doctor and vaccine recipient", a HSA spokesman said.